openPR Logo
Press release

Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market to 2025 | GlaxoSmithKline Plc, Helsinn Group, Heron Therapeutics, Merck & Co Inc, Tesaro

04-25-2019 08:39 AM CET | Health & Medicine

Press release from: Market Research Hub

Market Research Hub

Market Research Hub

Market Research Hub (MRH) has actively included a new research study titled “Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Insights, Forecast to 2025 to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until forecast period limit; 2025. In addition, a deep analysis of the competitive landscape, including prime market players is also enclosed in this report.

Get Sample Copy of This Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2274939

The global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs in these regions.
This research report categorizes the global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market by top players/brands, region, type and end user. This report also studies the global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline Plc
Helsinn Group
Heron Therapeutics
Merck & Co Inc
Tesaro

Market size by Product
Corticosteroids
Serotonin Antagonists
Dopamine Antagonists
NK-1 Inhibitors
Cannabinoids
Motion Sickness Treatments
Anti-Anxiety Drugs
Other
Market size by End User
High Emetic Risk Intravenous Chemotherapy
Moderate Emetic Risk Intravenous Chemotherapy
Low and Minimal Emetic Risk Intravenous Chemotherapy
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

BROWSE Full Report NOW @ https://www.marketresearchhub.com/report/global-chemotheraphy-induced-nausea-and-vomiting-cinv-drugs-market-insights-forecast-to-2025-report.html

Table of Contents

1 Study Coverage
1.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Product
1.4.2 Corticosteroids
1.4.3 Serotonin Antagonists
1.4.4 Dopamine Antagonists
1.4.5 NK-1 Inhibitors
1.4.6 Cannabinoids
1.4.7 Motion Sickness Treatments
1.4.8 Anti-Anxiety Drugs
1.4.9 Other
1.5 Market by End User
1.5.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by End User
1.5.2 High Emetic Risk Intravenous Chemotherapy
1.5.3 Moderate Emetic Risk Intravenous Chemotherapy
1.5.4 Low and Minimal Emetic Risk Intravenous Chemotherapy
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size
2.1.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue 2014-2025
2.1.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales 2014-2025
2.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Growth Rate by Regions
2.2.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Regions
2.2.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Manufacturers
3.1.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Manufacturers
3.1.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Manufacturers
3.1.3 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Manufacturers
3.2.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Price by Manufacturers
3.4 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

More Information………@@@

About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like pharmaceuticals market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,
Albany, NY 12207,
United States

Toll Free: 800-998-4852 (US-Canada)
Email: press@marketresearchhub.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market to 2025 | GlaxoSmithKline Plc, Helsinn Group, Heron Therapeutics, Merck & Co Inc, Tesaro here

News-ID: 1717310 • Views: 476

More Releases from Market Research Hub

Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Acrylate Polymers Market Professional Survey Report 2019”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Acrylate Polymers Market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, …
Market Research Hub (MRH) has recently uploaded a new study titled “Global Abrasive Wheels & Discs Market Professional Survey Report 2019” to its broad online storehouse. The global Abrasive Wheels & Discs Market conveniently covers prime factors motivating development and steering industry trends and demand scenarios. Readers can easily quantify market opportunities with the availability of information such as market sizing and market forecasting, thereby being able to analyze the
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Oral Dosing Cups Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Oral Dosing Cups market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstoc …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Opthalmic Lenses Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Opthalmic Lenses market*. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the

All 5 Releases


More Releases for Drugs

Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region. Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven
Immunotherapy Drugs Market
Immunotherapy drugs are used to treat cancer, infection, respiratory and autoimmune disorders. Immunotherapies either stimulate the activities done by specific components of the immune system or counteract the signals that are produced by the cancer cells and suppress the immune responses. The Immunotherapy Drugs Market accounted to USD 107 billion in 2016 growing at a CAGR of 13.2% during the forecast period of 2017 to 2024. The upcoming market report contains
Immunotherapy Drugs Market
Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some immunotherapies that suppress or reduce the immune response are known as suppression immunotherapies. Cell-based immunotherapies are useful for some types of cancers. Immune effector cells includingmacrophages, dendritic cells, lymphocytes, cytotoxic T lymphocytes (CTL), natural killer cells
Tardive Dyskinesia Drugs Market
Tardive dyskinesia (TD) is a form of dyskinesia that is difficult to treat. It is a nerve disorder characterized by involuntary movements such as jaw, lips, and tongue, considered as grimacing, sticking the tongue out, and lip smacking. Some other symptoms are an individual experiencing involuntary movement of the lower and upper extremities and also breathing choking. According to Center for Drug Evaluation and Research, tardive dyskinesia can lead to
Erythropoietin Drugs Market
Erythropoietin alfa is widely used to treat anemia and increase the red blood cells count in the body. Erythropoietin drugs are developed in vitro by extracting the erythropoietin from the human body and developing it through the use of recombinant DNA technology. Erythropoietin drugs are also used to treat anemia induced from cancer, multiple myloma and HIV associated anemia. Recombinant DNA technology has allowed researchers to develop synthetic forms of